Potassium Carbonate → 4-(7-(1-methyl-1H-pyrrol-3-yl)-8-(piperidin-4-yloxy)quinazolin-2-ylamino)benzenesulfonamide
반응식
C([O-])([O-])=O.[K+].[K+].Br[C:8]1[C:17]([O:18][CH:19]2[CH2:24][CH2:23][N:22](C(OC(C)(C)C)=O)[CH2:21][CH2:20]2)=[C:16]2[C:11]([CH:12]=[N:13][C:14]([NH:32][C:33]3[CH:38]=[CH:37][C:36]([S:39](=[O:42])(=[O:41])[NH2:40])=[CH:35][CH:34]=3)=[N:15]2)=[CH:10][CH:9]=1.[CH3:43][N:44]1[CH:48]=[CH:47][C:46](B2OC(C)(C)C(C)(C)O2)=[CH:45]1>COCCOC.[Pd]>[CH3:43][N:44]1[CH:48]=[CH:47][C:46]([C:8]2[C:17]([O:18][CH:19]3[CH2:20][CH2:21][NH:22][CH2:23][CH2:24]3)=[C:16]3[C:11]([CH:12]=[N:13][C:14]([NH:32][C:33]4[CH:34]=[CH:35][C:36]([S:39]([NH2:40])(=[O:41])=[O:42])=[CH:37][CH:38]=4)=[N:15]3)=[CH:10][CH:9]=2)=[CH:45]1참가 물질
반응물 3
생성물 1
시약·촉매·용매 2
반응 조건
- 온도
- 92.5 °C
실험 절차
A 2M solution of K2CO3 (180 μL) was added to a mixture of tert-butyl 4-(7-bromo-2-(4-sulfamoylphenylamino)quinazolin-8-yloxy)piperidine-1-carboxylate (18 mg, 0.031 mmole), 1-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole (20 mg, 0.093 mmole) and palladium (4 mg, 0.005 mmole) in DME (0.6 mL). The reaction was sparged with argon, sealed and heated at 90-95° C. with stirring. After 90 minutes, LCMS showed that the reaction had reached completion. The Boc group was removed by adding 4M HCl (1.5 mL) in dioxane to the cooled reaction mixture. After 2 hours, the reaction was complete by LCMS. The reaction was filtered, evaporated, dissolved in DMSO (1 mL) and purified by prep. HPLC to give 3.4 mg of the pure product as a TFA salt.
후처리
- customThe reaction was sparged with argon
- customsealed
- customThe Boc group was removed
- additionby adding 4M HCl (1.5 mL) in dioxane
- customto the cooled reaction mixture
- waitAfter 2 hours
- filtrationThe reaction was filtered
- customevaporated
- dissolutiondissolved in DMSO (1 mL)
- custompurified by prep
출처 및 근거
- ORD 기록
- ord-76489bad23784b35bc2f2a6b0e044c85
- 출처 데이터셋
- uspto-grants-2011_04
- 특허 번호
- US07932262B2
반응 노트
불러오는 중…